-
Study aim
-
Comparison onset,duration and quality of axillary block with ropivacaine 0.5% plus dexmedetomidine and fentanyl and Verapamil in forearm surgeries
-
Design
-
This study is clinical trial and double blind.105 patients candidate forearm surgery in Valiasr hospital will inter this study. We will divide patients in 3 groups by simple randomization. Groups are parallel.
-
Settings and conduct
-
This study is clinical trial and double blind.105 patients candidate forearm surgery in Valiasr hospital will inter this study. Outcome assessor and analyzer not aware from grouping. Codes of group are available to analyzer and outcome assessor.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:20 to 70 years, fracture of the forearm and hand, absence more than a fracture in the body or surgery, body mass index less than 35, not having blood coagulation and disorder PTT and PT and INR, lack of psychological problems, no pregnancy, absence of neurological disorders in the hand
Exclusion criteria: Failure to cooperate with the patient to perform the block, allergy to drug, infection in block area, surgical time more than 150 minutes, block failure
-
Intervention groups
-
First group: We inject 40 milliliter of Ropivacaine 0.5 % plus 1 micro gram in kilogram Dexmedetomidine.
Second group:We inject 40 milliliter of Ropivacaine 0.5 % plus 1 micro gram in kilogram Fentanyl.
Third group:We inject 40 milliliter of Ropivacaine 0.5 % plus 2.5 milligram Verapamil in kilogram Dexmedetomidine.
-
Main outcome variables
-
blood pressure, heart rate, oxygen saturation, pain, duration motor and sensory block, drug consumption